Drug Resistant Models
Comprehensive portfolio of drug resistant models representing clinically relevant mechanisms of resistance:
- 10+ cancer types
- 25+ key targets
- 30+ leading drugs
- 100+ resistant models
- Extensive validation data
Our capabilities include cutting-edge bioinformatics and analytical techniques to enable a clear and in-depth understanding of resistance mechanisms
Leverage our extensive panel of CDK4/6 inhibitor resistant breast cancer models
Drug Resistant Models
Related Content
Strategies to stimulate dendritic cell (DC) activity, such as ex vivo generation and priming of DC vaccines, have been explored...
VIEW RESOURCENatural killer (NK) cells play a crucial role in the immune system and can recognize and kill cancer cells. Research...
VIEW RESOURCE